As of 2025-02-10, the Relative Valuation of United Therapeutics Corp (UTHR) is 686.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 347.71 USD, the upside of United Therapeutics Corp based on Relative Valuation is 97.4%.
The range of the Relative Valuation is 456.40 - 1,007.87 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 40.5x | 28.6x |
| Forward P/E multiples | 19.9x - 34.1x | 26.6x |
| Fair Price | 456.40 - 1,007.87 | 686.43 |
| Upside | 31.3% - 189.9% | 97.4% |
| Date | P/E |
| 2025-02-07 | 13.97 |
| 2025-02-06 | 14.21 |
| 2025-02-05 | 14.23 |
| 2025-02-04 | 14.20 |
| 2025-02-03 | 14.25 |
| 2025-01-31 | 14.11 |
| 2025-01-30 | 14.16 |
| 2025-01-29 | 14.98 |
| 2025-01-28 | 14.90 |
| 2025-01-27 | 14.85 |
| 2025-01-24 | 14.90 |
| 2025-01-23 | 14.94 |
| 2025-01-22 | 14.92 |
| 2025-01-21 | 14.79 |
| 2025-01-17 | 14.42 |
| 2025-01-16 | 14.72 |
| 2025-01-15 | 14.53 |
| 2025-01-14 | 14.65 |
| 2025-01-13 | 14.58 |
| 2025-01-10 | 14.67 |
| 2025-01-08 | 14.73 |
| 2025-01-07 | 14.56 |
| 2025-01-06 | 14.28 |
| 2025-01-03 | 14.32 |
| 2025-01-02 | 14.47 |
| 2024-12-31 | 14.18 |
| 2024-12-30 | 14.37 |
| 2024-12-27 | 14.46 |
| 2024-12-26 | 14.63 |
| 2024-12-24 | 14.50 |
| 2024-12-23 | 14.61 |
| 2024-12-20 | 14.45 |
| 2024-12-19 | 14.47 |
| 2024-12-18 | 14.37 |
| 2024-12-17 | 15.26 |
| 2024-12-16 | 14.98 |
| 2024-12-13 | 14.54 |
| 2024-12-12 | 14.53 |
| 2024-12-11 | 14.55 |
| 2024-12-10 | 14.56 |
| 2024-12-09 | 14.75 |
| 2024-12-06 | 14.85 |
| 2024-12-05 | 15.04 |
| 2024-12-04 | 15.04 |
| 2024-12-03 | 14.82 |
| 2024-12-02 | 14.87 |
| 2024-11-29 | 14.89 |
| 2024-11-27 | 15.19 |
| 2024-11-26 | 15.15 |
| 2024-11-25 | 14.81 |